Photo of Brian McCalmon

Brian McCalmon is a Litigation shareholder in Vedder Price’s Washington, DC office, focusing on Antitrust and Consumer Protection. His antitrust practice focuses on conduct and merger investigations and cases brought by the Antitrust Division of the Department of Justice, the Federal Trade Commission and state attorneys general. He also represents companies in investigations of marketing, advertising, and privacy practices before the FTC and other consumer protection agencies.

In September 2025, the Federal Trade Commission (“FTC”) took steps to crack down on anticompetitive employee non‑competes even as the FTC abandoned the Biden Administration’s efforts to broadly ban them by rule.  As a first step, on September 4, 2025, the FTC launched an inquiry seeking the public’s input on the prevalence and use of non-competes by employers, stating that “[w]ith the assistance of the employees and workers most burdened by them, the Trump-Vance FTC intends to uproot the worst offenders and restore fairness to the American labor market.”  The next day, the FTC filed a consent decree in an unfair competition action against Gateway Services, Inc. and a subsidiary, premised on its employee non-compete agreements.  The consent decree requires Gateway to stop enforcing non-competes binding its nearly 1800 workers.  On September 10, FTC Chair Andrew Ferguson issued warning letters to several undisclosed healthcare companies and staffing agencies for “includ[ing] noncompete agreements … in employment contracts that may unreasonably limit employment options for vital roles like nurses, physicians, and other medical professionals.”  And, on September 17, the FTC announced a workshop focused on “Protecting Workers from Anticompetitive Noncompete Agreements.” The workshop was to be held on October 8 but has been delayed because of the federal government shutdown.Continue Reading FTC Again Targets Unfair Employee Non-Competes

Last month, we posted an update describing Florida’s investigation into whether the CDP and the Science Based Targets Initiative are facilitating unlawful collusion among financial institutions and investment services to use an environmental “scoring system” to make investment decisions. On August 12, 2025, the Federal Trade Commission (the “FTC”) fired another warning shot across the

Florida’s Attorney General announced an investigation on July 28, 2025 into whether the CDP (formerly known as the Climate Disclosure Project) and the Science Based Targets Initiative (SBTi) have violated consumer protection or antitrust laws by “coercing companies into disclosing proprietary data and paying for access under the guise of environmental transparency.”  According to the AG, the CDP charges companies to report, revise and promote their environmental disclosure data, “while selling services that allegedly improve scores and even offer favorable quotes from CDP executives for a price.”  The AG alleges that this scoring system is relied upon by investment companies to make financial decisions.  The investigation will, among other things, explore whether “CDP’s efforts to pressure or punish companies that don’t participate result in anticompetitive effects,” and whether “coordination between CDP, financial institutions, and investment services constitutes unlawful market manipulation.”Continue Reading Florida AG Investigation Is Latest Reminder of Risk Tied to Green Initiatives

The FTC is designating July as “Made in America Month,” and manufacturers in all industries should understand the restrictions they face when marketing their products as produced in the US.  The Trump Administration’s tariffs will drive manufacturing further onshore and will increase the perceived value of marketing products as Made in the USA, in turn driving increased scrutiny of such claims.  The consequences for not complying with the FTC’s Made in the USA rules can be steep, including potential penalties of up to $50,120 per violation (for 2025) and a heightened risk that a competitor will sue for damages under § 43(a) of the Lanham Act.Continue Reading FTC Highlights “Made in the USA” Standards for July

In an eight-page Statement joined by the two other sitting Commissioners, FTC Chair Andrew Ferguson on May 30, 2025 explained his reasoning for accepting a divestiture remedy proposed by Synopsis, Inc. and Ansys, Inc. to resolve concerns stemming from their pending merger.  The parties to the merger had proposed divesting standalone or discrete business units in three relevant markets to resolve FTC concerns.  The Statement, while promising a forthcoming policy statement on merger remedies, set forth a clear viewpoint about the role of remedies in merger antitrust enforcement and drew a stark contrast with the stance carved out by the Biden FTC, which had expressed a general hostility to remedies and a preference for litigation. 

The Statement is notable for a couple of reasons.  First, it recognizes the key role acquisitions play in fostering innovation.  The Biden FTC expressed antipathy toward acquisitions, particularly by private equity.  Chair Ferguson’s Statement, in contrast, expressly credits the capital from acquisitions as providing “fuel for the fires of innovation,” which in turn spurs the development of “new technology and economic growth.”  Chair Ferguson appears to be sending a clear signal that the days of FTC’s general skepticism of acquisitions—particularly of smaller startups by private equity or larger, more established companies—are over.Continue Reading FTC Chair Issues Statement on Merger Remedies

On Monday, April 14, 2025, a federal jury convicted Eduardo “Eddie” Lopez of conspiring to fix the wages for home healthcare nurses in Las Vegas and for fraudulently failing to disclose the criminal antitrust investigation during the sale of his home healthcare staffing company.  According to the complaint and trial evidence, Lopez, who oversaw recruitment, hiring, retention and assignments of nurses for three home health agencies, conspired with unnamed conspirators in a series of meetings and communications to artificially cap the wages of Las Vegas-area nurses between March 2016 and May 2019.  He will be sentenced on July 14 for one count of participating in a wage-fixing conspiracy and five counts of wire fraud. Continue Reading DOJ Notches First Trial Win in Wage-Fixing Case

On April 10, 2025, the Senate confirmed Mark Meador to serve as the third Republican on the Federal Trade Commission (FTC) in a 50-46 party line vote. Commissioner Meador takes his seat on a Commission now comprised of three Republicans and no Democrats since President Trump fired Democratic Commissioners Slaughter and Bedoya in March. The

In the first major initiative of the Antitrust Division within the Trump Administration’s Department of Justice, the DOJ announced on March 28, 2025 the creation of a task force to “advocate for the elimination of anticompetitive state and federal laws and regulations that undermine free market competition and harm consumers, workers, and businesses.” Citing President Trump’s Executive Order 14219, which mandated such reviews, the DOJ’s announcement called out for special scrutiny the “regulatory capture” of agencies by “special interests and big businesses” in five economic sectors:  housing, transportation, food and agriculture, healthcare, and energy.Continue Reading U.S. Department of Justice Launches “Anticompetitive Regulations” Task Force

The FTC took two actions on February 26, 2025 to emphasize its continued focus on labor markets and to rededicate its efforts to a policy priority in common with those of the previous Administration.  First, the FTC approved a Final Order requiring a building service contractor to stop enforcing a no-hire agreement with its customers.  Second, FTC Chair Andrew Ferguson directed the FTC to form a Joint Labor Task Force dedicated to “protecting … American consumers in their roles as workers.”Continue Reading Pair of FTC Actions Underscores Continued Focus on Labor Issues

Federal Trade Commission Chairman Andrew Ferguson announced to FTC staff on February 18 that the FTC would retain the 2023 Merger Guidelines as the framework for reviewing mergers and acquisitions. Citing the need for stability between presidential administrations, Chairman Ferguson rejected calls to set aside the 2023 Merger Guidelines to draft new ones or reinstate